scieee Open visual document viewer

Coxsackie-adenovirus receptor expression is enhanced in pancreas from patients with type 1 diabetes

Hodik, M,Anagandula, M,Fuxe, J,Krofvold, L,Dahl-Jorgensen, K,Hyöty, H,Sarmiento, L,Frisk, G,POD-V Consortium

Abstract

Objectives One of the theories connecting enterovirus (EV) infection of human islets with type 1 diabetes (T1D) is the development of a fertile field in the islets. This implies induction of appropriate proteins for the viral replication such as the coxsackie–adenovirus receptor (CAR). The aim of this study was to investigate to what extent CAR is expressed in human islets of Langerhans, and what conditions that would change the expression. Design Immunohistochemistry for CAR was performed on paraffin-embedded pancreatic tissue from patients with T1D (n=9 recent onset T1D, n=4 long-standing T1D), islet autoantibody-positive individuals (n=14) and non-diabetic controls (n=24) individuals. The expression of CAR was also examined by reverse transcription PCR on microdissected islets (n=5), exocrine tissue (n=5) and on explanted islets infected with EV or exposed to chemokines produced by EV-infected islet cells. Results An increased frequency of patients with T1D and autoantibody-positive individuals expressed CAR in the pancreas (p<0.039). CAR staining was detected more frequently in pancreatic islets from patients with T1D and autoantibody-positive subjects (15/27) compared with (6/24) non-diabetic controls (p<0.033). Also in explanted islets cultured in UV-treated culture medium from coxsackievirus B (CBV)-1-infected islets, the expression of the CAR gene was increased compared with controls. Laser microdissection of pancreatic tissue revealed that CAR expression was 10-fold higher in endocrine compared with exocrine cells of the pancreas. CAR was also expressed in explanted islets and the expression level decreased with time in culture. CBV-1 infection of explanted islets clearly decreased the expression of CAR (p<0.05). In contrast, infection with echovirus 6 did not affect the expression of CAR. Conclusions CAR is expressed in pancreatic islets of patients with T1D and the expression level of CAR is increased in explanted islets exposed to proinflammatory cytokines/chemokines produced by infected islets. T1D is associated with increased levels of certain chemokines/cytokines in the islets and this might be the mechanism behind the increased expression of CAR in TID islets.

Full text

Coxsackie–adeno i us ecep o exp ession is enhanced in panc eas om pa ien s wi h ype 1 diabe es M Hodik, 1 M Anagandula, 1 J Fuxe, 2 L K og old, 3 K Dahl-Jø gensen, 3 H Hyö y, 4,5 L Sa mien o, 6 G F isk, 1 POD-V Conso ium To ci e: Hodik M, Anagandula M, Fuxe J, e al. Coxsackie–adeno i us ecep o exp ession is enhanced in panc eas om pa ien s wi h ype 1 diabe es. BMJ Open Diabe es Resea ch and Ca e 2016;4:e000219. doi:10.1136/bmjd c-2016- 000219 ▸Addi ional ma e ial is a ailable. To iew please isi he jou nal (h p://dx.doi.o g/ 10.1136/bmjd c-2016- 000219). Recei ed 29 Feb ua y 2016 Re ised 8 June 2016 Accep ed 9 July 2016 Fo numbe ed a ilia ions see end o a icle. Co espondence o D Gun F isk; gun.e gida. [email p o ec ed] ABSTRACT Objec i es: One o he heo ies connec ing en e o i us (EV) in ec ion o human isle s wi h ype 1 diabe es (T1D) is he de elopmen o a e ile ield in he isle s. This implies induc ion o app op ia e p o eins o he i al eplica ion such as he coxsackie– adeno i us ecep o (CAR). The aim o his s udy was o in es iga e o wha ex en CAR is exp essed in human isle s o Lange hans, and wha condi ions ha would change he exp ession. Design: Immunohis ochemis y o CAR was pe o med on pa a in-embedded panc ea ic issue om pa ien s wi h T1D (n=9 ecen onse T1D, n=4 long-s anding T1D), isle au oan ibody-posi i e indi iduals (n=14) and non-diabe ic con ols (n=24) indi iduals. The exp ession o CAR was also examined by e e se ansc ip ion PCR on mic odissec ed isle s (n=5), exoc ine issue (n=5) and on explan ed isle s in ec ed wi h EV o exposed o chemokines p oduced by EV-in ec ed isle cells. Resul s: An inc eased equency o pa ien s wi h T1D and au oan ibody-posi i e indi iduals exp essed CAR in he panc eas (p<0.039). CAR s aining was de ec ed mo e equen ly in panc ea ic isle s om pa ien s wi h T1D and au oan ibody-posi i e subjec s (15/27) compa ed wi h (6/24) non-diabe ic con ols (p<0.033). Also in explan ed isle s cul u ed in UV- ea ed cul u e medium om coxsackie i us B (CBV)-1-in ec ed isle s, he exp ession o he CAR gene was inc eased compa ed wi h con ols. Lase mic odissec ion o panc ea ic issue e ealed ha CAR exp ession was 10- old highe in endoc ine compa ed wi h exoc ine cells o he panc eas. CAR was also exp essed in explan ed isle s and he exp ession le el dec eased wi h ime in cul u e. CBV-1 in ec ion o explan ed isle s clea ly dec eased he exp ession o CAR (p<0.05). In con as , in ec ion wi h echo i us 6 did no a ec he exp ession o CAR. Conclusions: CAR is exp essed in panc ea ic isle s o pa ien s wi h T1D and he exp ession le el o CAR is inc eased in explan ed isle s exposed o p oin lamma o y cy okines/chemokines p oduced by in ec ed isle s. T1D is associa ed wi h inc eased le els o ce ain chemokines/cy okines in he isle s and his migh be he mechanism behind he inc eased exp ession o CAR in TID isle s. INTRODUCTION Type 1 diabe es (T1D) is a li elong disease cha ac e ized by he loss o o se e ely educed numbe o insulin-p oducing βcells in he isle o Lange hans, p esence o isle au oan ibodies and, especially in younge indi iduals, insuli is consis ing o infil a ion o he isle s p edominan ly by CD8+ T cells and mac ophages. The e iology o he disease is unclea bu i has been shown ha gene ic ac o s, especially genes in he human leuco- cy e an igen (HLA) complex, a e o majo impo ance o he pa hogenesis. In addi ion, se e al s udies ha e shown ha en i onmen- al ac o s likely con ibu e o disease de el- opmen . 12 En e o i uses (EVs), pa icula ly he coxsackie i us B (CBV), a e among he main en i onmen al candida es and nume - ous s udies ha e shown associa ion be ween hese gu i uses and T1D by di e en ech- niques. 3–10 In addi ion, expe imen s using isola ed human isle s ha e shown ha CBVs a e able o in ec and eplica e in insulin- p oducing βcells. 411–13 CBV belong o he human en e o i us species B (HEV-B) species. Thei genome is Signi icance o his s udy Wha is al eady known abou his subjec ? ▪I is known ha en e o i us, especially Coxsackie i us B, o en can be de ec ed in human isle s o Lange hans in ype 1 diabe es cases. Wha a e he new indings? ▪I is no known i and o wha ex en isle cells exp ess app op ia e i us ecep o s and i he exp ession di e s be ween ype 1 diabe es cases, p e-diabe ic cases and non-diabe es indi iduals. How migh hese esul s change he ocus o esea ch o clinical p ac ice? ▪Ou inding ha he Coxsackie-Aden i us- Recep o (CAR) is mo e equen ly exp essed in panc eas om p e-diabe ic and in ype 1 dia- be es cases compa ed o con ol indi iduals sugges he p esence o a e ile ield in panc eas in he wo o me g oups. BMJ Open Diabe es Resea ch and Ca e 2016;4:e000219. doi:10.1136/bmjd c-2016-000219 1 Open Access Resea ch g oup.bmj.com on Decembe 1, 2016 - Published by h p://d c.bmj.com/Downloaded om ∼7500 nucleo ides long and p o ec ed by a capsid com- posed o 180 subuni s o he capsid p o eins VP1–VP4. The i ions use a ious ecep o molecules o en e he cell. The main ecep o o CBVs is he igh junc- ion p o ein Coxsackie–adeno i us ecep o (CAR), which belongs o he la ge amily o adhesion molecules; howe e , o he ecep o s ha e also been shown o be impo an o i us in e naliza ion. 14 15 The ull-leng h CAR p o ein comp ises wo ex acellula immunoglobulin-like domains (D1 and D2), one ans- memb ane helix and an in acellula C- e minal domain. 16 17 A leas fi e iso o ms o CAR a e known, wo ansmemb ane iso o ms, which di e only a hei C- e minal, and h ee lacking he ansmemb ane domain ha we e shown o be sec e ed in ans ec ed HeLa cells. 18–20 CBV binds he dis al end o he D1 domain in he canyon o he i us capsid, 21 whe eas he in acellula C domain has been shown o be dispensable o in ec ion. 22 The issue dis ibu ion o CAR in human issues has been mainly s udied a he ansc ip ional le el; CAR is exp essed in a a ie y o human o gans, including he panc eas. 19 23 The p o ein is highly exp essed in he b ain and hea du ing mu ine emb y- onic de elopmen , bu exp ession declines apidly a e bi h. 24 25 Exp ession o he CAR p o ein in human adul panc eas has been demons a ed in duc al epi he- lial cells, 26 isle cells, 27 and exoc ine acina cells (h p:// www.p o eina las.o g) by immunohis ochemis y (IHC). Which o he iso o ms o he CAR p o ein is p esen in panc eas, and he biological unc ions o hese a e no known. A monoclonal an ibody di ec ed agains he ex acellula CAR domain 28 blocked eplica ion o CBV-4 and CBV-5 in explan ed isle s, an indi ec p oo o exp es- sion and unc ion in human isle s. 4 Fu he mo e, he exp ession o he CAR p o ein has been no ed o be inc eased du ing healing and inflamma ion 29 30 and down egula ed in a ious human cance s. 31 The main aim o his s udy was o in es iga e he exp ession o he CAR gene and p o ein in panc ea ic issue, ob ained om di e en g oups o pa ien s wi h T1D, and o compa e i wi h non-diabe ic con ol indi i- duals. We also wan ed o s udy how EV in ec ion o i us-induced inflamma o y media o s egula e he exp ession o CAR in human isle s. MATERIALS AND METHODS Tissue specimen Panc ea ic pa a fin-embedded issue om he panc ea ic head o ail we e ob ained om non-diabe ic dono s wi h isle cell au oan ibodies (n=14), dono s wi h ecen onse T1D (n=9, bo h om o gan dono s and om he DiViD s udy), dono s wi h long-s anding T1D (n=5), and om con ol, au oan ibody-nega i e, non-diabe ic o gan dono s (n=24). Tissues om o gan dono s we e p o- ided by he Ne wo k o Panc ea ic O gan Dono s wi h Diabe es (nPOD) and he Uppsala biobank. Panc eas biopsies we e ob ained om he DiViD biobank, Oslo, No way (see online supplemen a y able S1). Human isle and cell cul u es Panc ea ic isle s we e isola ed om he panc eas o o gan dono s acco ding o he p o ocol by Go o e al. 32 Isle s we e hen handpicked unde a ligh mic oscope o u he inc ease pu i y o >90%. Isle s we e cul u ed ee floa ing in six-well pla es o suspension cul u es (Sa s ed , Nümb ech , Ge many) in 3 mL RPMI-1640 5.5 mM glucose (SVA, Uppsala Sweden) supplemen ed wi h 10% e al bo ine se um (FBS) (Gibco, In i ogen, S ockholm, Sweden). G een Monkey Kidney (GMK) cells we e cul u ed in 96-well pla es (Co ning, New Yo k, USA) in Eagle’s minimum essen ial medium (EMEM) (SVA, Uppsala Sweden) supplemen ed wi h 10% FBS (Gibco, In i ogen, S ockholm, Sweden). All cells we e cul u ed a 37°C in 5% CO 2 . P olonged cul u e o isle s Human isle s, isola ed and u he pu ified by handpick- ing, we e cul u ed as desc ibed abo e wi h change o cul u e medium e e y hi d day. To al RNA was ex ac ed on days 1, 4, 8 and 13 (numbe o dono s=2) pos isola- ion o analyze he genes coding o CAR and insulin. E hics The wo k pe o med on human issue was in acco dance wi h he p inciples exp essed in he Decla a ion o Helsinki and he Eu opean Council’s Con en ion on Human Righ s and Biomedicine. Isola ion o human isle s o Lange hans and he esea ch pe o med on hese was app o ed by he Regional E hics Commi ee in Uppsala, Sweden. Collec ion o panc ea ic issue in he DiViD s udy was app o ed by he No wegian Go e nmen Regional E hics Commi ee in Oslo, No way. Vi us Th ee s ains o CBV-1 we e used in he gene exp ession s udy: CBV-1-7-10796 and CBV-1-11-10802 we e isola ed in A gen ina du ing 1983 and 1998, espec i ely, whe eas CBV-1-3-10790 was isola ed in he USA in 1973. All s ains we e ob ained om he Cen e o Disease Con ol and P e en ion (CDC), A lan a, Geo gia, USA. In addi ion, a s ain o echo i us 6 (Echo-6-2C) was included in his s udy. This s ain was isola ed in Cuba 2011 om a pa ien wi h meningi is as a pa o he Public Heal h Su eillance s a egies in Cuba on ci cula - ing EV in meningi is cases. The CBV-1 s ains we e chosen since CBV-1 has been shown o use CAR as i s main ecep o . The Echo-6-2C s ain was chosen since his se o ype does no use CAR as a ecep o and has been shown o bind o CD55/decay accele a ing ac o . 33 Immunohis ochemis y Pa a fin-embedded o malin-fixed panc ea ic issue as well as pa a fin-embedded o malin-fixed explan ed isle s o Lange hans we e sec ioned (5 µm) and d ied on Supe os glass slides (Menzel-Gläze , Fische scien ific, B aunschweig, Ge many), ollowed by de-pa a finiza ion and ehyd a ion in 99.70% e hanol. An igen e ie al 2BMJ Open Diabe es Resea ch and Ca e 2016;4:e000219. doi:10.1136/bmjd c-2016-000219 Isle s udies g oup.bmj.com on Decembe 1, 2016 - Published by h p://d c.bmj.com/Downloaded om was pe o med in TE-bu e , pH 9 (DAKO, Glos up, Denma k) in a s eam boile and pe meabilized in TBS con aining 0.05% TWEEN 20. Endogenous pe oxidase was blocked by he use o a eady- o use pe oxidase blocke (DAKO, Glos up, Denma k). A e insing, he sec ions we e incuba ed wi h p ima y an ibodies, mouse an i-CAR (RmcB clone, Millipo e, Bille ica, Massachuse s, USA) dilu ed 1:1000. Incuba ion wi h hese an ibodies was pe o med a oom empe a u e o 1 hou and he isualiza ion was achie ed wi h he an i- mouse En ision-ki (Dako, Glos up, Denma k) using 3,3’-diaminobenzidine (DAB) as subs a e ch omogen. Fo double s aining wi h CAR and ch omog anin A (mouse, eady o use, Dako, Glos up), he sec ions we e isualized using a Polink DS MM D ki polyme -HRP&AP double s aining ki (Golden B idge, Mukil eo, Washing on, USA). Vi us in ec ion Handpicked human isle s o Lange hans we e inocula- ed wi h any o he i us s ains o ob ain a final concen- a ion o 10 3 issue cul u e in ec ious dose (TCID) 50 . Aliquo s o he cul u e medium we e collec ed on he day o in ec ion and e e y day un il day 3 pos in ec ion (p.i.) o i us eplica ion measu emen by TCID 50 i a- ions, and s o ed a −20°C. On day 3 p.i., all isle s and all cells de ached om he isle s du ing cul u e we e spun down and washed be o e o al RNA was ex ac ed. Isle s inocula ed wi h he CBV-1-11 s ain we e also ha - es ed o wes e n blo (WB) analysis on day 3 p.i. Fo IHC analysis, isle s om he same dono we e inocula ed wi h CBV-1-11 a a final concen a ion o 10 2.5–3 TCID 50 o mock-in ec ed. On day 4 p.i., hey we e fixed and embedded. Analysis o i us eplica ion Vi us eplica ion was de e mined by TCID 50 i a ions o samples o cul u e medium on an in house cell line o i- gina ing om GMK cells, ob ained om Go henbu g Uni e si y, Sweden, as desc ibed p e iously. 34 The samples we e collec ed om he in ec ed isle cul u es on he indica ed days p.i. T ea men wi h i us-induced p oin lamma o y chemokines The e ec o inflamma o y media o s on he exp ession le el o he CAR gene was analyzed by ea ing explan ed isle s wi h UV- ea ed cul u e medium om CBV-1-in ec ed human isle s ( wo dono s) and by adding CXCL10 (Pep o ech, S ockholm, Sweden) a final concen a ions o 0.1, 10 and 50 ng/mL ( ou dono s) o 1 and 4 days. To al RNA was ex ac ed and he exp ession o he gene encoding CAR was analyzed by quan i a i e e e se ansc ip ion PCR. RNA ex ac ion and cDNA syn hesis Th ee days p.i., isola ed human panc ea ic isle s we e washed in phospha e-bu e ed saline (PBS) and lysed by using RLT bu e (Qiagen, Sollen una, Sweden) on QIAsh edde spin columns (Qiagen, Sollen una, Sweden). To al RNA was ex ac ed om he in ec ed and con ol isle s by using he RNAeasy mini ki (Qiagen, Sollen una, Sweden) wi h G DNA elimina o column o emo e he genomic DNA. RNA concen a- ion and quali y we e de e mined wi h Nanod op (The mo Scien ific, B aunschweig, Ge many). Up o 50 ng o o al RNA pe sample was e e se ansc ibed o cDNA in a eac ion mix u e o 0.5 µL andom p ime (300 ng/μL, In i ogen, S ockholm, Sweden), 1 µL RNaseOUT (40 U/µL), 4 µL 5× fi s s and bu e , and 1 µL 0.1 M di hio h ei ol (DTT) acco ding o he manu- ac u e ’s ins uc ions. Reac ion was ca ied ou a 25°C o 10 min, 42°C o 55 min, and 15 min a 75°C. Real- ime PCR The mRNA exp ession le el o genes encoding CAR, insulin, and amylase was analyzed wi h eal- ime PCR. The eac ion mix u e consis ing o 10 µL Sybe G een mas e mix (Applied Biosys ems, S ockholm, Sweden), 2 µL p ime , and 1 µL cDNA was p epa ed acco ding o he manu ac u e ’s ins uc ions. The eac ion was ca ied ou in a 96-well op ical pla e on a S ep one plus Real- ime PCR sys em (Applied Biosys ems, S ockholm, Sweden). The cycling condi ions we e 40 cycles o 15 s a 94°C, 30 s a 55°C and 30 s a 68°C. P edesigned p ime s (Qun i ec , Qiagen, Sollen una Sweden) we e used o de ec ion o CAR and 18s. Also, o amylase and insulin, comme cially a ailable p ime s we e used o analyses o he LMC samples. Real- ime PCR da a we e analyzed by he compa a i e del a c me hod. The exp ession le el o he gene encoding CAR was no malized o he exp ession o he 18s housekeep- ing gene by sub ac ing he 18s c alue om CAR gene c alues. The ela i e gene exp ession le els we e calcula ed by using he 2^- dc o mula and p esen ed as he clus e ed columns in MS Excel. Mel cu e analysis was used o e i y he specifici y o final PCR p oduc s. Wes e n blo Exp ession o he CAR p o ein was analyzed in explan ed human isle s in ec ed wi h CBV-1-11 and mock in ec ed by WB using a polyclonal an ibody (α-CAR20) as p e iously desc ibed, 35 using an an ibody agains calnexin (BioNo dika Sweden AB, S ockholm) as loading con ol. S a is ical analyses Linea eg ession and ORs wi h 95% CIs we e used o es he likelihood o CAR posi i i y in g ouped T1D dono s and non-diabe ic con ols. Owing o low sample sizes, he likelihood o CAR posi i i y in he sepa a e T1D g oups was only measu ed be ween au oan ibody- posi i e dono s and non-diabe ic con ols. Di e ences in gene exp ession le els be ween con ol and i us-in ec ed samples, be ween di e en dono s and be ween he CBV-1 s ains we e analyzed wi h he K uskal-Wallis es (co esponding o he pa ame ic BMJ Open Diabe es Resea ch and Ca e 2016;4:e000219. doi:10.1136/bmjd c-2016-000219 3 Isle s udies g oup.bmj.com on Decembe 1, 2016 - Published by h p://d c.bmj.com/Downloaded om one-way analysis o a iance), when compa ing da a om mo e han wo independen g oups, and he Mann-Whi ney es (co esponding o he pa ame ic independen samples - es ), when compa ing da a om wo independen g oups. Co ela ion analyses be ween he exp ession o amylase and exoc ine issue, insulin and endoc ine issue, and CAR and endoc ine/exoc ine issue we e pe o med wi h Spea man’s . The p<0.05 was conside ed s a is ically significan . All ba s a e p e- sen ed as mean+SEM. RESULTS Immunohis ochemis y CAR posi i i y was significan ly highe in he combined T1D and isle au oan ibody-posi i e g oup (15/27 com- pa ed wi h con ols (6/24) in linea eg ession (p<0.033), wi h an OR o 3.877 and be ween isle au oan ibody-posi i e subjec s and non-diabe ic con ols (p<0.039)). The exac figu e o his highe equency o CAR-posi i e s aining in he endoc ine isle s o ecen onse T1D was 5/9, isle au oan ibody-posi i e 8/14, and long-s anding subjec s wi h T1D 2/4 compa ed wi h con- ols 6/24. To be conside ed posi i e, he sec ion s ained posi i e o CAR in a ew up o se e al isle s. In CAR-nega i e sec ions om ei he g oup o dono s, no s aining o CAR was seen. The posi i e CAR s aining e ealed a memb anous pa e n in he endoc ine issue (figu e 1A), sugges ing he p esence o he ansmem- b aneous pa o CAR. A somewha less in ense cy oplasmic/memb anous CAR s aining was also obse ed in cells in he exoc ine pa o he panc eas in all dono s, wi h CAR-posi i e endoc ine cells. In addi ion, in fi e dono s wi h T1D, posi i e s aining o CAR in duc al epi helial cells was seen. In he majo i y (30/51) o he panc ea ic sec ions (mainly con ols), no s aining o he ex acellula domain o CAR was seen in he endoc ine o exoc ine issue. Vi us eplica ion All EV s ains/se o ypes used o in ec ion eplica ed in he isle s. The mean i us i e inc ease in he cul u e medium du ing 3 days p.i. was 10 1.8+0.28 (CBV-1-11, n=6), 10 2.5+0.4 (CBV-1-3, n=7), 10 2.5+0.40 (CBV-1-7, n=6) and 10 4.5+0.19 (echo i us 6-2C, n=5) TCID 50 /200 µL, espec - i ely (figu e 2). Exp ession o CAR mRNA In unin ec ed con ol isle s (n=3), cul u ed o an ex ended pe iod pos isola ion, he exp ession le el o CAR dec eased linea ly wi h he ime o cul u e (figu e 3). Isle s in ec ed in i o wi h h ee s ains o CBV-1 e ealed a significan (p<0.001) educ ion in CAR coding mRNA compa ed wi h unin ec ed con ol isle s om he same dono s (n=6). The e we e no di e - ences be ween he CBV-1 s ains in ha espec . Howe e , in isle s in ec ed wi h echo i us-6-2C, which does no use CAR as a ecep o , no educ ion o he exp ession o CAR mRNA was seen compa ed wi h con ol (figu e 4), indica ing ha he e ec was no due o i us-induced β-cell dea h. Compa ing he exp ession le el o CAR be ween he di e en CBV-1 s ains and he Echo-6-2C e ealed ha he di e ence was simila o ha o he di - e ence be ween he con ol and he CBV-1-in ec ed isle s. Figu e 2 Mean i us i e inc ease in human isle s, om con ol dono s, in ec ed in i o wi h CBV-1-3 (n=7), CBV-1-7 (n=6), CBV-1-11 (n=6) and Echo-6-2C (n=5). CBV, coxsackie i us B. Figu e 1 (A) Posi i e CAR s aining in one dono wi h GAD65 and IA-2 au oan ibodies. (B) CAR s aining in isola ed human isle s, om con ol o gan dono , in ec ed wi h a CBV-1 s ain. CAR, coxsackie–adeno i us ecep o ; CBV, coxsackie i us B. 4BMJ Open Diabe es Resea ch and Ca e 2016;4:e000219. doi:10.1136/bmjd c-2016-000219 Isle s udies g oup.bmj.com on Decembe 1, 2016 - Published by h p://d c.bmj.com/Downloaded om CBV-1-11 and CBV-1-3 di e ed somewha mo e compa ed wi h Echo-6-2C (p<0.009) han CBV-1-7 (p<0.004). In explan ed isle s cul u ed in UV- ea ed cul u e medium om in ec ed isle s om o gan dono s, a clea inc ease o CAR mRNA was seen a e 4 days o cul u e compa ed wi h isle s cul u ed in UV- ea ed isle cul u e medium om con ols (figu e 5). Wes e n blo The educ ion o he CAR gene seen in isle s in ec ed wi h s ains o CBV-1 was also confi med on he p o ein le el. The e was a dec eased exp ession o he CAR p o ein ela i e o he housekeeping p o ein in isle s in ec ed wi h CBV-1-11 compa ed wi h ha in mock- in ec ed isle s om he same dono (figu e 6). DISCUSSION In his s udy, we ound ha equency o CAR exp ession was inc eased in he panc ea ic endoc ine issue om au oan ibody-posi i e non-diabe ic dono s and subjec s wi h T1D compa ed wi h con ols. This indica es ha CAR may p omo e i us in ec ion and up ake in endo- c ine cells o panc ea ic isle s, p e iously shown o be pe missi e o i us in ec ion bo h in i o 4 and in i o. 12 The eason o he highe pe cen age CAR posi i i y in pa ien s wi h T1D and p ediabe es is no known, bu s udies ha e shown ha CAR exp ession can be induced by inflamma ion and issue damage. 29 CAR has been shown o be an inducible p o ein and inc eased exp es- sion o CAR has been epo ed in myocy es in dila ed ca diomyopa hy 30 and in hea s om subjec s wi h myo- ca dial in a c ion. 24 Inc eased CAR exp ession has also been associa ed wi h an ongoing inflamma ion 29 and du ing o ma ion o cell- o-cell con ac due o issue des uc ion. 24 25 In ac , we ound ha UV- ea ed cul u e supe na an s o CBV-in ec ed isle s induced simila CAR exp ession on cul u e isle s, sugges ing ha Figu e 4 Mean CAR mRNA exp ession le els in isola ed human isle s om con ol dono s in ec ed in i o wi h di e en EV s ains. CAR exp ession le els we e dec eased in all isle s in ec ed wi h s ains o CBV-1 compa ed wi h he mock-in ec ed con ol (p<0.05). In isle s in ec ed wi h he non-CAR using E6-2C s ain, no a ec on he CAR exp ession le el was seen. Ba s ep esen mean±SEM. CAR, coxsackie– adeno i us ecep o ; CBV, coxsackie i us B; E6-2C, Echo-6-2C; EV, en e o i us. Figu e 3 mRNA exp ession le els o he gene encoding CAR in isola ed human isle s om con ol dono s, cul u ed o p olonged ime (n=2). Isle s we e cul u ed o 1, 4, 8 and 12 days and CAR mRNA exp ession le els we e quan i ied wi h qPCR. CAR, coxsackie–adeno i us ecep o ; qPCR, quan i a i e PCR. Figu e 5 mRNA exp ession le els o he gene encoding CAR in explan ed human isle s om con ol dono s, cul u ed in UV- ea ed cul u e medium de i ed om CBV-in ec ed human isle s and om mock in ec ed isle s. CAR mRNA exp ession le els we e quan i ied wi h qPCR on day 4 o cul u e. CAR, coxsackie–adeno i us ecep o ; CBV, coxsackie i us B; qPCR, quan i a i e PCR; UV, ul a iole . Figu e 6 Wes e n blo analysis o explan ed human isle s om con ol dono s in ec ed in i o wi h CBV-1-11 e ealed dec eased exp ession o he CAR p o ein compa ed wi h mock-in ec ed isle s om he same dono (n=1). CAR, coxsackie–adeno i us ecep o ; CBV, coxsackie i us B. BMJ Open Diabe es Resea ch and Ca e 2016;4:e000219. doi:10.1136/bmjd c-2016-000219 5 Isle s udies g oup.bmj.com on Decembe 1, 2016 - Published by h p://d c.bmj.com/Downloaded om CBV in ec ion in isle s o Lange hans could be one pos- sible cause o CAR exp ession in isle s. This supe na an did no con ain in ec ious i us pa icles, sugges ing ha he e ec was due o some inflamma o y media o s induced by he i us in in ec ed isle s. P e ious s udies ha e shown ha CBV in ec ion o human isle s induces se e al cy okines and chemokines. 36 37 We es ed he e ec o one o he mos abundan ly p oduced chemo- kines, CXCL10, on isle s, bu i ailed o induce CAR. Thus, u he s udies a e needed o iden i y i us-induced subs ances ha media e induc ion o CAR on human isle s. In addi ion o i al ac o s, o he ac o s, such as he au oimmune p ocess i sel , may be in ol ed. Rega dless o he cause o he induc ion o he splice a ian o CAR ha is used by CBV o in ec ion, induc- ion o his p o ein may make isle mo e suscep ible o CBV in ec ion and also p omo e he sp ead o ongoing in ec ion o o he isle s. 17 The exp ession o CAR in isle s om dono s wi h isle au oan ibodies o T1D sugges s ha isle s in hese indi i- duals a e po en ially mo e suscep ible o CBV in ec ion. In humans, in con as o in mice, i seems ha isle o Lange hans a e he a ge issue o CBV. In con as o ou findings in humans, in si u hyb idiza ion in panc e- a ic issue om mice has ailed o show any exp ession o CAR mRNA in he isle s 38 ha migh explain why mouse isle s a e no mally spa ed du ing CBV in ec ion. 38 39 Mos s udies ha e ailed o de ec EV in human exo- c ine issue, ha is, in neona es wi h sys emic EV in ec- ions. 4 In i o s udies, in which p ima y human exoc ine cells we e inocula ed wi h wo s ains o CBV-5, ailed o show any eplica ion and no i us pa icles could be de ec ed by elec on mic oscopy in he cells. 12 S aining o he ex acellula domain o CAR on pan- c ea ic issue sec ions e ealed ha mos non-diabe ic dono s did no exp ess he ex acellula domain o CAR. In con as , CAR (p o ein and gene) was exp essed in explan ed isle s om all dono s es ed. P olonged cul u e o isola ed isle s e ealed ha he exp ession o he CAR gene dec eased wi h ime o cul u e, sugges ing ha he diges i e p ocess o he panc eas du ing isle isola ion migh cause an induc ion o CAR. In i o in ec ion o isle s wi h EVs e ealed ha in isle s in ec ed wi h CAR using i uses, he exp ession o CAR was dec eased, in con as in ec ion wi h a non-CAR using EV, he exp ession le el o CAR was no a ec ed. One possible explana ion o he educed exp ession could be a species-specific down egula ion o i us ecep o s, which migh lead o inhibi ion o in ec- ion by a second i us, he so-called supe in ec ion exclusion. 40 This phenomenon has also been desc ibed o se e al o he i uses 41 and migh a o a slow- g owing, pe sis en s ain. Whe he he down egula ion is due o s imula ion o ce ain cy okines, which in i o ha e been shown o dec ease he exp ession le el o he CAR gene 42 and also he CAR p o ein by p omo ion o u no e o CAR p o ein h ough ubiqui- in–p o easome and nuclea ac o kappa-ligh -chain- enhance o ac i a ed B cells (NFkB)-dependen pa h- ways 43 o some o he ac o s, emains o be elucida ed. A mo e likely explana ion migh be ha CAR is down- egula ed by hsa-miR-466d; his has ecen ly been shown in a oden b-cell model challenged wi h CBV-4. 44 In con as o he dec eased exp ession o CAR du ing an acu e CBV in ec ion in isle endoc ine cells, he exp ession o CAR in indi iduals wi h acu e EV in ec ion in myocy es was inc eased. 30 Also in EV-posi i e cases wi h dila ed ca diomyopa hy, a disease wi h a ch onic EV in ec ion, he exp ession o he CAR p o ein was inc eased compa ed wi h con ols. 45 Sys emic EV in ec- ion has du ing some epidemics esul ed in se ocon e - sion o isle - ela ed au oan ibodies, indica ing ha i al eplica ion has aken place in he isle cells, wi h elease o in acellula p o eins as a esul . 46 I such an in ec ion, in a subg oup o in ec ed indi iduals, p og essed o a ch onic phase wi h a low-g ade i al eplica ion and ongoing issue damage, CAR migh be induced by EV in ec ion. This has been shown ega ding myoca di is and i s p og ession in some indi iduals o dila ed myopa hy. 47 In summa y, his s udy shows ha he CAR p o ein is exp essed in isle s o Lange hans in a highe pe cen age o indi iduals wi h T1D o a isk o T1D compa ed wi h non-diabe ic indi iduals. Inc eased exp ession o CAR is also seen a e ea men wi h p oinflamma o y cy o- kines/chemokines, and induc ion o his p o ein in pan- c ea ic isle s in i o migh induce a e iled field and his may also p omo e he sp ead o CBV o o he isle and play a ole in i us-induced T1D. Au ho a ilia ions 1 Depa men o Immunology, Gene ics and Pa hology, Uppsala Uni e si y, The Rudbeck Labo a o y, Uppsala, Uppland, Sweden 2 Depa men o Mic obiology, Tumo and Cell biology, Ka olinska Ins i u e , S ockholm, Sweden 3 Di ision o Paedia ic and Adolescen Medicine, Oslo Uni e si y Hospi al, Oslo and Facul y o Medicine, Uni e si y o Oslo, Oslo, No way 4 Depa men o Vi ology, Uni e si y o Tampe e, Tampe e, Finland 5 FimlabLabo a o ies, Pi kanmaa Hospi al Dis ic , Tampe e, Finland 6 Au oimmuni y Uni , Depa men o Clinical Sciences, Skåne Uni e si y Hospi al, Lund Uni e si y, Malmo, Sweden Acknowledgemen s The au ho s hank Inga Hansson o he echnical assis ance wi h he IHC. Collabo a o s POD-V Conso ium, h p://www.jd npod.o g/publica ions/ npod- i al-wo k-g oup/. Funding This wo k was suppo ed by unding om he Eu opean Union’s Se en h F amewo k P og amme PEVNET (FP7/2007–2013) unde g an ag eemen numbe 261441 and om a Diabe es Resea ch Wellness Founda ion Non-clinical Resea ch Fellowship, Ba ndiabe es onden, Swedish diabe es associa ion and Ne wo k o Panc ea ic O gan Dono s wi h Diabe es (nPOD), a collabo a i e ype 1 diabe es esea ch p ojec sponso ed by he Ju enile Diabe es Resea ch Founda ion In e na ional (JDRF). The DiViD s udy was unded by he No weigian Sou h Eas Hel h Region, The No o No disk Founda ion and PEVNET. O gan P ocu emen O ganiza ions (OPO) pa ne ing wi h nPOD o p o ide esea ch esou ces a e lis ed a h p://www.jd npod.o g/ ou -pa ne s.php. 6BMJ Open Diabe es Resea ch and Ca e 2016;4:e000219. doi:10.1136/bmjd c-2016-000219 Isle s udies g oup.bmj.com on Decembe 1, 2016 - Published by h p://d c.bmj.com/Downloaded om Compe ing in e es s None decla ed. E hics app o al The e hical commi ee a Oslo uni e si y hospi al and he e hical commi ee a Uppsala Uni e si y. P o enance and pee e iew No commissioned; ex e nally pee e iewed. Da a sha ing s a emen No addi ional da a a e a ailable. Open Access This is an Open Access a icle dis ibu ed in acco dance wi h he C ea i e Commons A ibu ion Non Comme cial (CC BY-NC 4.0) license, which pe mi s o he s o dis ibu e, emix, adap , build upon his wo k non- comme cially, and license hei de i a i e wo ks on di e en e ms, p o ided he o iginal wo k is p ope ly ci ed and he use is non-comme cial. See: h p:// c ea i ecommons.o g/licenses/by-nc/4.0/ REFERENCES 1. Kond asho a A, Reunanen A, Romano A, e al. A six- old g adien in he incidence o ype 1 diabe es a he eas e n bo de o Finland. Ann Med 2005;37:67–72. 2. Redondo MJ, Je ey J, Fain PR, e al. Conco dance o isle au oimmuni y among monozygo ic wins. N Engl J Med 2008;359:2849–50. 3. Elshebani A, Olsson A, Wes man J, e al. E ec s on isola ed human panc ea ic isle cells a e in ec ion wi h s ains o en e o i us isola ed a clinical p esen a ion o ype 1 diabe es. Vi us Res 2007;124:193–203. 4. Ylipaas o P, Klingel K, Lindbe g AM, e al. En e o i us in ec ion in human panc ea ic isle cells, isle opism in i o and ecep o in ol emen in cul u ed isle be a cells. Diabe ologia 2004;47:225–39. 5. Richa dson SJ, Lee e P, Bone AJ, e al. Exp ession o he en e o i al capsid p o ein VP1 in he isle cells o pa ien s wi h ype 1 diabe es is associa ed wi h induc ion o p o ein kinase R and down egula ion o Mcl-1. Diabe ologia 2013;56:185–93. 6. Oika inen S, Ma iskainen M, Tau iainen S, e al. En e o i us RNA in blood is linked o he de elopmen o ype 1 diabe es. Diabe es 2011;60:276–9. 7. Yoon JW, Aus in M, Onode a T, e al. Isola ion o a i us om he panc eas o a child wi h diabe ic ke oacidosis. N Engl J Med 1979;300:1173–9. 8. Yin H, Be g AK, Tu emo T, e al. En e o i us RNA is ound in pe iphe al blood mononuclea cells in a majo i y o ype 1 diabe ic child en a onse . Diabe es 2002;51:1964–71. 9. F isk G, Fohlman J, Kobbah M, e al. High equency o coxsackie-B- i us-speci ic IgM in child en de eloping ype I diabe es du ing a pe iod o high diabe es mo bidi y. J Med Vi ol 1985;17: 219–27. 10. K og old L, Edwin B, Buanes T, e al. De ec ion o a low-g ade en e o i al in ec ion in he isle s o Lange hans o li ing pa ien s newly diagnosed wi h ype 1 diabe es. Diabe es 2015;64:1682–7. 11. F isk G, Dide holm H. Tissue cul u e o isola ed human panc ea ic isle s in ec ed wi h di e en s ains o coxsackie i us B4: assessmen o i us eplica ion and e ec s on isle mo phology and insulin elease. In J Exp Diabe es Res 2000;1:165–75. 12. Hodik M, Lukinius A, Ko sg en O, e al. T opism analysis o wo coxsackie B S ains e eals i us g ow h in human p ima y panc ea ic isle s bu no in exoc ine cell clus e s in i o. Open Vi ol J 2013;7:49–56. 13. Anagandula M, Richa dson S, Skog O, e al. In ec ion o human isle s o Lange hans wi h wo s ains o coxsackie B i us se o ype 1; assessmen o i us eplica ion, deg ee o cell dea h and induc ion o genes in ol ed in he inna e immuni y pa hway. J Med Vi ol 2014;86:1402–11. 14. F isk G, El s om T, Dide holm H. The eplica ion o ce ain coxsackie B i us s ains in CHO cells. J Vi ol Me hods 2001;98: 161–5. 15. Sha en DR, Ba es RC, Ag ez MV, e al. Coxsackie i uses B1, B3, and B5 use decay accele a ing ac o as a ecep o o cell a achmen . J Vi ol 1995;69:3873–7. 16. Be gelson JM, Cunningham JA, D ogue G, e al. Isola ion o a common ecep o o coxsackie B i uses and adeno i uses 2 and 5. Science 1997;275:1320–3. 17. Be gelson JM, K i hi as A, Celi L, e al. The mu ine CAR homolog is a ecep o o coxsackie B i uses and adeno i uses. J Vi ol 1998;72:415–19. 18. Exco on KJ, Ganseme ND, Mobily ME, e al. Iso o m-speci ic egula ion and localiza ion o he coxsackie and adeno i us ecep o in human ai way epi helia. PLoS ONE 2010;5:e9909. 19. Thoelen I, Magnusson C, Tage ud S, e al. Iden i ica ion o al e na i e splice p oduc s encoded by he human coxsackie-adeno i us ecep o gene. Biochem Biophys Res Commun 2001;287:216–22. 20. Do ne A, Xiong D, Couch K, e al. Al e na i ely spliced soluble coxsackie-adeno i us ecep o s inhibi coxsackie i us in ec ion. J Biol Chem 2004;279:18497–503. 21. He Y, Chipman PR, Howi J, e al. In e ac ion o coxsackie i us B3 wi h he ull leng h coxsackie i us-adeno i us ecep o . Na S uc Biol 2001;8:874–8. 22. Wang X, Be gelson JM. Coxsackie i us and adeno i us ecep o cy oplasmic and ansmemb ane domains a e no essen ial o coxsackie i us and adeno i us in ec ion. J Vi ol 1999;73:2559–62. 23. Tomko RP, Xu R, Philipson L. HCAR and MCAR: he human and mouse cellula ecep o s o subg oup C adeno i uses and g oup B coxsackie i uses. P oc Na l Acad Sci USA 1997;94:3352–6. 24. Fechne H, Nou sias M, Tschoepe C, e al. Induc ion o coxsackie i us-adeno i us- ecep o exp ession du ing myoca dial issue o ma ion and emodeling: iden i ica ion o a cell- o-cell con ac - dependen egula o y mechanism. Ci cula ion 2003;107:876–82. 25. Honda T, Sai oh H, Masuko M, e al. The coxsackie i us-adeno i us ecep o p o ein as a cell adhesion molecule in he de eloping mouse b ain. B ain Res Mol B ain Res 2000;77:19–28. 26. Raschpe ge E, Thybe g J, Pe e sson S, e al. The coxsackie- and adeno i us ecep o (CAR) is an in i o ma ke o epi helial igh junc ions, wi h a po en ial ole in egula ing pe meabili y and issue homeos asis. Exp Cell Res 2006;312:1566–80. 27. D esche KM, Kono K, Bopegamage S, e al. Coxsackie i us B3 in ec ion and ype 1 diabe es de elopmen in NOD mice: insuli is de e mines suscep ibili y o panc ea ic isle s o i us in ec ion. Vi ology 2004;329:381–94. 28. Hsu KH, Lonbe g-Holm K, Als ein B, e al. A monoclonal an ibody speci ic o he cellula ecep o o he g oup B coxsackie i uses. J Vi ol 1988;62:1647–52. 29. I o M, Kodama M, Masuko M, e al. Exp ession o coxsackie i us and adeno i us ecep o in hea s o a s wi h expe imen al au oimmune myoca di is. Ci c Res 2000;86:275–80. 30. Nou sias M, Fechne H, de Jonge H, e al. Human coxsackie-adeno i us ecep o is colocalized wi h in eg ins alpha( ) be a(3) and alpha( )be a(5) on he ca diomyocy e sa colemma and up egula ed in dila ed ca diomyopa hy: implica ions o ca dio opic i al in ec ions. Ci cula ion 2001;104:275–80. 31. Kus e K, Koschel A, Rohwe N, e al. Down egula ion o he coxsackie and adeno i us ecep o in cance cells by hypoxia depends on HIF-1alpha. Cance Gene The 2010;17: 141–6. 32. Go o M, Eich TM, Felldin M, e al. Re inemen o he au oma ed me hod o human isle isola ion and p esen a ion o a closed sys em o in i o isle cul u e. T ansplan a ion 2004;78:1367–75. 33. Be gelson JM, Chan M, Solomon KR, e al. Decay-accele a ing ac o (CD55), a glycosylphospha idylinosi ol-ancho ed complemen egula o y p o ein, is a ecep o o se e al echo i uses. P oc Na l Acad Sci USA 1994;91:6245–8. 34. Moell A, Skog O, Ahlin E, e al. An i i al e ec o nico inamide on en e o i us-in ec ed human isle s in i o: e ec on i us eplica ion and chemokine sec e ion. J Med Vi ol 2009;81:1082–7. 35. Nys öm N, Be g T, Lundin E, e al. Human en e o i us species B in ileocecal Ch on’s disease. Clin T ansl Gas oen e ol 2013 Jun 27; 4:e38. 36. Olsson A, Johansson U, Ko sg en O, e al. In lamma o y gene exp ession in coxsackie i us B-4-in ec ed human isle s o Lange hans. Biochem Biophys Res Commun 2005;330:571–6. 37. Anagandula M, Richa dson SJ, Obe s e MS, e al. In ec ion o human isle s o Lange hans wi h wo s ains o coxsackie B i us se o ype 1: assessmen o i us eplica ion, deg ee o cell dea h and induc ion o genes in ol ed in he inna e immuni y pa hway. J Med Vi ol 2014;86:1402–11. 38. Mena I, Fische C, Gebha d JR, e al. Coxsackie i us in ec ion o he panc eas: e alua ion o ecep o exp ession, pa hogenesis, and immunopa hology. Vi ology 2000;271:276–88. 39. Bopegamage S, Ko aco a J, Va go a A, e al. Coxsackie B i us in ec ion o mice: inocula ion by he o al ou e p o ec s he panc eas om damage, bu no om in ec ion. J Gen Vi ol 2005;86(P 12):3271–80. 40. Tsche ne DM, E ans MJ, on Hahn T, e al. Supe in ec ion exclusion in cells in ec ed wi h hepa i is C i us. J Vi ol 2007;81:3693–703. 41. Simon KO, Ca damone JJ J , Whi ake -Dowling PA, e al. Cellula mechanisms in he supe in ec ion exclusion o esicula s oma i is i us. Vi ology 1990;177:375–9. BMJ Open Diabe es Resea ch and Ca e 2016;4:e000219. doi:10.1136/bmjd c-2016-000219 7 Isle s udies g oup.bmj.com on Decembe 1, 2016 - Published by h p://d c.bmj.com/Downloaded om 42. Vincen T, Pe e sson RF, C ys al RG, e al. Cy okine-media ed down egula ion o coxsackie i us-adeno i us ecep o in endo helial cells. J Vi ol 2004;78:8047–58. 43. Gao Y, Lui WY. Syne gis ic e ec o in e e on-gamma and umo nec osis ac o -alpha on coxsackie i us and adeno i us ecep o exp ession: an explana ion o cell sloughing du ing es icula in lamma ion in mice. Biol Rep od 2014;90:59. 44. Lam WY, Cheung AC, Tung CK, e al. miR-466 is pu a i e nega i e egula o o coxsackie i us and adeno i us ecep o . FEBS Le 2015;589:246–54. 45. Liu Q, Su XJ, Yu Y, e al. Co ela ions among pe sis en i al in ec ion, hea unc ion and Chinese medicine synd omes in dila ed ca diomyopa hy pa ien s. Chin J In eg Med 2014;20:928–33. 46. Sa mien o L, Cubas-Duenas I, Cab e a-Rode E. E idence o associa ion be ween ype 1 diabe es and exposu e o en e o i us in Cuban child en and adolescen s. MEDICC Re 2013;15:29–32. 47. Chapman NM, Kim KS, D esche KM, e al. 5 e minal dele ions in he genome o a coxsackie i us B2 s ain occu ed na u ally in human hea . Vi ology 2008;375:480–91. 8BMJ Open Diabe es Resea ch and Ca e 2016;4:e000219. doi:10.1136/bmjd c-2016-000219 Isle s udies g oup.bmj.com on Decembe 1, 2016 - Published by h p://d c.bmj.com/Downloaded om 1 diabe es ypeenhanced in panc eas om pa ien s wi h adeno i us ecep o exp ession is−Coxsackie L Sa mien o, G F isk and POD-V Conso ium M Hodik, M Anagandula, J Fuxe, L K og old, K Dahl-Jø gensen, H Hyö y, doi: 10.1136/bmjd c-2016-000219 2016 4: BMJ Open Diab Res Ca e h p://d c.bmj.com/con en /4/1/e000219 Upda ed in o ma ion and se ices can be ound a : These include: Re e ences #BIBLh p://d c.bmj.com/con en /4/1/e000219 This a icle ci es 46 a icles, 17 o which you can access o ee a : Open Access h p://c ea i ecommons.o g/licenses/by-nc/4.0/non-comme cial. See: p o ided he o iginal wo k is p ope ly ci ed and he use is non-comme cially, and license hei de i a i e wo ks on di e en e ms, pe mi s o he s o dis ibu e, emix, adap , build upon his wo k Commons A ibu ion Non Comme cial (CC BY-NC 4.0) license, which This is an Open Access a icle dis ibu ed in acco dance wi h he C ea i e se ice Email ale ing box a he op igh co ne o he online a icle. Recei e ee email ale s when new a icles ci e his a icle. Sign up in he Collec ions Topic A icles on simila opics can be ound in he ollowing collec ions (3)Isle s udies No es h p://g oup.bmj.com/g oup/ igh s-licensing/pe missions To eques pe missions go o: h p://jou nals.bmj.com/cgi/ ep in o m To o de ep in s go o: h p://g oup.bmj.com/subsc ibe/ To subsc ibe o BMJ go o: g oup.bmj.com on Decembe 1, 2016 - Published by h p://d c.bmj.com/Downloaded om